- Home
- PLSE vs AMRC Comparison
PLSE vs AMRC Comparison
Compare PLSE & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | AMRC |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2015 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PLSE | AMRC |
|---|---|---|
| Price | $19.08 | $30.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $22.00 | ★ $37.88 |
| AVG Volume (30 Days) | 210.1K | ★ 429.7K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,769,928,000.00 |
| Revenue This Year | $840.00 | $10.71 |
| Revenue Next Year | $287.54 | $9.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 28.76 |
| 52 Week Low | $12.56 | $12.95 |
| 52 Week High | $26.30 | $44.93 |
Technical Indicators
Market Signals| Indicator | PLSE | AMRC |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 58.83 |
| Support Level | $17.32 | $29.05 |
| Resistance Level | $20.40 | $31.12 |
| Average True Range (ATR) | 1.37 | 1.74 |
| MACD | -0.40 | 0.32 |
| Stochastic Oscillator | 12.11 | 56.76 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About AMRC Ameresco Inc.
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.